Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A comprehensive map of the evidence on the performance evaluation indicators of public hospitals: a scoping study and best fit framework synthesis.

Pourmohammadi K, Hatam N, Shojaei P, Bastani P.

Cost Eff Resour Alloc. 2018 Dec 6;16:64. doi: 10.1186/s12962-018-0166-z. eCollection 2018.

2.

Patient Involvement in Care and Breast Cancer Patients’ Quality of Life- a Structural Equation Modeling (SEM) Approach

Dehghan H, Keshtkaran A, Ahmadloo N, Bagheri Z, Hatam N.

Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2511-2517.

3.

The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine.

Javan-Noughabi J, Rezapour A, Kassani A, Hatam N, Ahmadloo N.

J Res Med Sci. 2018 Jun 6;23:57. doi: 10.4103/jrms.JRMS_644_17. eCollection 2018.

4.
5.

Epidemiology of Animal Bites and Factors Associated With Delays in Initiating Post-exposure Prophylaxis for Rabies Prevention Among Animal Bite Cases: A Population-based Study.

Esmaeilzadeh F, Rajabi A, Vahedi S, Shamsadiny M, Ghelichi Ghojogh M, Hatam N.

J Prev Med Public Health. 2017;50(3):210-216. doi: 10.3961/jpmph.17.027.

6.

Neonatal Screening: Cost-utility Analysis for Galactosemia.

Hatam N, Askarian M, Shirvani S, Siavashi E.

Iran J Public Health. 2017 Jan;46(1):112-119.

7.

Comparing knowledge and self-reported hand hygiene practices with direct observation among Iranian hospital nurses.

Seyed Nematian SS, Palenik CJ, Mirmasoudi SK, Hatam N, Askarian M.

Am J Infect Control. 2017 Jun 1;45(6):e65-e67. doi: 10.1016/j.ajic.2017.03.007. Epub 2017 Apr 18.

PMID:
28427787
8.

Economic Burden of Avoidable Hospitalizations among Patients with Cancer at Namazi Hospital in Shiraz, 2013

Hatam N, Fanusi T, Dehghani M, Vojdani R, Ramzi M, Askarian M.

Asian Pac J Cancer Prev. 2017 Jan 1;18(1):177-182.

9.

Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran

Hatam N, Ahmadloo N, Vazirzadeh M, Jafari A, Askarian M.

Asian Pac J Cancer Prev. 2016 Dec 1;17(12):5309-5314.

10.

Equity analysis of hospital beds distribution in Shiraz, Iran 2014.

Hatam N, Zakeri M, Sadeghi A, Darzi Ramandi S, Hayati R, Siavashi E.

Med J Islam Repub Iran. 2016 Jul 9;30:393. eCollection 2016.

11.

Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.

Hatam N, Bastani P, Shahtaheri RS.

J Res Pharm Pract. 2016 Jul-Sep;5(3):181-5. doi: 10.4103/2279-042X.185725.

12.
13.
14.
15.

Assessment of Three "WHO" Patient Safety Solutions: Where Do We Stand and What Can We Do?

Banihashemi S, Hatam N, Zand F, Kharazmi E, Nasimi S, Askarian M.

Int J Prev Med. 2015 Dec 9;6:120. doi: 10.4103/2008-7802.171391. eCollection 2015.

16.

Using Queuing Theory and Simulation Modelling to Reduce Waiting Times in An Iranian Emergency Department.

Haghighinejad HA, Kharazmi E, Hatam N, Yousefi S, Hesami SA, Danaei M, Askarian M.

Int J Community Based Nurs Midwifery. 2016 Jan;4(1):11-26.

17.

Technical efficiency of Shiraz school of medicine in research and education domains: a data envelopment analysis.

Delavari S, Rezaee R, Hatam N, Delavari S.

J Adv Med Educ Prof. 2016 Jan;4(1):13-20.

18.

Cost-Utility of "Doxorubicin and Cyclophosphamide" versus "Gemcitabine and Paclitaxel" for Treatment of Patients with Breast Cancer in Iran.

Hatam N, Askarian M, Javan-Noghabi J, Ahmadloo N, Mohammadianpanah M.

Asian Pac J Cancer Prev. 2015;16(18):8265-70.

19.

Cost-Utility Analysis of IEV Drug Regimen Versus ESHAP Drug Regimen for the Patients With Relapsed and Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran.

Hatam N, Dehghani M, Habibian M, Jafari A.

Iran J Cancer Prev. 2015 Oct;8(5):e4061. doi: 10.17795/ijcp-4061. Epub 2015 Oct 27.

20.
21.

The economic burden of traumatic brain injury due to fatal traffic accidents in shahid rajaei trauma hospital, shiraz, iran.

Kavosi Z, Jafari A, Hatam N, Enaami M.

Arch Trauma Res. 2015 Mar 20;4(1):e22594. doi: 10.5812/atr.22594. eCollection 2015 Mar.

22.

Horizontal inequity in access to outpatient services among Shiraz City residents, Iran.

Kavosi Z, Mohammadbeigi A, Ramezani-Doroh V, Hatam N, Jafari A, Firoozjahantighi A.

J Res Health Sci. 2015 Winter;15(1):37-41.

23.

Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran.

Vazin A, Zamani Z, Hatam N.

Drug Healthc Patient Saf. 2014 Dec 11;6:179-84. doi: 10.2147/DHPS.S75223. eCollection 2014.

24.
25.

Factors affecting the technical efficiency of health systems: A case study of Economic Cooperation Organization (ECO) countries (2004-10).

Ravangard R, Hatam N, Teimourizad A, Jafari A.

Int J Health Policy Manag. 2014 Jun 8;3(2):63-9. doi: 10.15171/ijhpm.2014.60. eCollection 2014 Jul.

26.

The financial cost of preventive and curative programs for breast cancer: a case study of women in Shiraz-Iran.

Hatam N, Keshtkar V, Salehi A, Rafei H.

Int J Health Policy Manag. 2014 May 8;2(4):187-91. doi: 10.15171/ijhpm.2014.44. eCollection 2014 May.

27.

Cost-utility analysis of neonatal screening program, shiraz university of medical sciences, shiraz, iran, 2010.

Hatam N, Shirvani S, Javanbakht M, Askarian M, Rastegar M.

Iran J Pediatr. 2013 Oct;23(5):493-500.

28.

Cost-effectiveness of rabies post exposure prophylaxis in Iran.

Hatam N, Esmaelzade F, Mirahmadizadeh A, Keshavarz K, Rajabi A, Afsar Kazerooni P, Ataollahi M.

J Res Health Sci. 2014 Spring;14(2):122-7.

29.

Adherence to American Heart Association and American College of Cardiology standard guidelines of angiography in Shiraz, Iran.

Hatam N, Banikhalaf A, Ostovan MA, Askarian M.

Arch Iran Med. 2013 Oct;16(10):568-72. doi: 0131610/AIM.003.

30.

Cost efficiency of the family physician plan in fars province, southern iran.

Hatam N, Joulaei H, Kazemifar Y, Askarian M.

Iran J Med Sci. 2012 Dec;37(4):253-9.

31.

Supplemental Content

Loading ...
Support Center